Complaint Granted In Novartis Bone Drug Case
Despite objections by Novartis Pharmaceutical Corp., a district court has allowed plaintiffs who allege the pharmaceutical giant's bone cancer drugs cause jawbone decay to divide into a proposed class seeking dental...To view the full article, register now.
Already a subscriber? Click here to view full article